BPC-157 + TB-500 Blend

BPC-157 + TB500

10mg / Vial

£30.00

BPC-157 + TB500

£30.00

Size 10mg 20mg

Type Vial Pen

Third-party tested

1–2 day tracked dispatch

Discreet packaging

99%+ purity guaranteed

For Research Use OnlyThis compound is strictly for laboratory and in-vitro research. Not for human consumption or medical use.

Reconstitution

Pen format? Pens are supplied pre-mixed and ready for research use — no reconstitution required. The steps below apply to lyophilized vials only.

Swab both vial stoppers with alcohol and allow to dry.
Draw the required volume of bacteriostatic water with a sterile syringe.
Add the water slowly down the inside wall of the vial — never directly onto the powder.
Swirl gently until fully dissolved. Never shake.
Confirm the solution is clear and particle-free.
Label with date and concentration, then refrigerate at 2–8 °C.

Full guide & dose calculator

Storage & Handling

Lyophilized vials: refrigerate sealed at 2–8 °C away from light; freeze at −20 °C for storage beyond 6 months.
After reconstitution: refrigerate at 2–8 °C; typically stable 4–8 weeks with bacteriostatic water. Do not freeze once mixed.
Pre-mixed pens: arrive ready to use — refrigerate at 2–8 °C with the cap on and never freeze.
General: avoid direct sunlight, heat and repeated temperature swings; minimise agitation.

Quality & Shipping FAQ

Is this compound tested? Yes — every batch is third-party tested by accredited labs (HPLC & mass spectrometry) at 99%+ verified purity.
How is it supplied? As lyophilized powder in a sealed sterile vial (or pre-mixed pen where offered), with research-use labelling.
How fast is dispatch? 1–2 working day dispatch, 2–3 days UK delivery, in plain discreet packaging.
What is it for? Strictly laboratory and in-vitro research — not for human or veterinary consumption, medical use or self-administration.

View the peer-reviewed research

Packaging update Our branded boxes are temporarily out of stock. Until new stock lands, orders ship in plain, discreet packaging — the same product inside, sealed and dispatched with the same care. Thank you for your patience.

BPC-157 and TB-500 are two of the most extensively studied peptides in tissue-repair and recovery research. This blend pairs them in a single vial for laboratory investigation.

About the compounds

BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a sequence identified in gastric juice. It has been the subject of extensive preclinical research examining pathways involved in angiogenesis, growth-factor signalling and connective-tissue models.

TB-500 is a synthetic form of the active region of Thymosin Beta-4, a naturally occurring peptide studied for its role in cell migration and actin regulation in laboratory models.

Specifications

Purity: 99%+ (third-party verified)
Independently tested before dispatch
Presented as lyophilised (freeze-dried) powder
Supplied for in-vitro laboratory research only

FAQ

Is it tested? Yes — every batch is independently tested to 99%+ purity before dispatch.
What form does it arrive in? Lyophilised powder.
What is this sold for? Laboratory and research use only. Not for human or animal consumption.

⚖ For Laboratory Research Use Only — Not for Human Consumption.

BPC-157 Tissue Research Animal Model

BPC-157: Angiogenic & Cytoprotective Properties in In-Vitro Models

Journal of Physiology and Pharmacology · Sikiric et al., 2018

BPC-157 (Body Protection Compound-157) is a pentadecapeptide derived from a gastric protein. In-vitro and animal model studies have demonstrated its angiogenic properties, including upregulation of VEGFR2 expression and promotion of endothelial cell migration. Research has also investigated its cytoprotective effects on gastrointestinal tissue at the cellular level, with consistent replication across multiple independent research groups.

Angiogenesis Cytoprotection VEGFR2

BPC-157 Tissue Research Animal Model

BPC-157: Tendon Outgrowth, Cell Survival and Musculoskeletal Repair

Journal of Applied Physiology · Chang et al., 2011

BPC-157 has been extensively researched for musculoskeletal repair mechanisms. Chang et al. demonstrated that BPC-157 promoted tendon healing through three parallel mechanisms: stimulation of tendon outgrowth, enhanced cell survival under oxidative stress, and accelerated tendon cell migration in scratch assay models. Rodent studies document significantly accelerated healing of Achilles tendon, quadriceps, and rotator cuff injuries, alongside upregulation of EGR1 and VEGF.

Tendon Repair Cell Migration EGR1 / VEGF

BPC-157 Tissue Research Animal Model

BPC 157 Accelerates Healing of Transected Rat Achilles Tendon

J. Orthopaedic Research · Staresinic et al., 2003

A controlled rat model in which the Achilles tendon was fully transected and treated with BPC-157 or saline. BPC-157-treated animals showed significantly faster functional recovery and improved biomechanical and histological healing of the tendon. This is among the foundational preclinical studies establishing BPC-157's musculoskeletal repair profile.

Achilles Tendon Biomechanics Animal Model

TB-500 Tissue Research Animal Model

Thymosin β4 Accelerates Wound Healing

J. Investigative Dermatology · Malinda et al., 1999

In a rat full-thickness wound model, thymosin β4 (the parent molecule of TB-500) applied topically or intraperitoneally increased re-epithelialisation by 42% at four days and up to 61% at seven days versus saline controls. Treated wounds also showed increased collagen deposition and angiogenesis, consistent with the peptide's actin-regulating, pro-migratory mechanism.

Re-epithelialisation Angiogenesis Animal Model

TB-500 Tissue Research In-Vitro

TB-500: Thymosin Beta-4 Fragment and Actin Dynamics in Cellular Repair Models

Annals of the New York Academy of Sciences · Philp et al., 2004

TB-500 is a synthetic peptide fragment of Thymosin Beta-4 corresponding to the actin-binding domain at amino acid positions 17–23. Research confirms this region as the primary G-actin sequestering domain of the parent molecule. In vitro studies demonstrate TB-500's role in promoting cell migration, stimulating angiogenesis through upregulation of VEGF, and reducing inflammatory markers in wound healing models.

Actin Sequestration VEGF Wound Healing

Thymosin β4 Cellular Biology In-Vitro

Thymosin Beta-4: Actin Sequestration and Cellular Motility Research

Annals of the New York Academy of Sciences · Goldstein & Kleinman, 2015

Thymosin Beta-4 is a ubiquitous 43-amino acid peptide that plays a critical role in actin polymerisation and cellular motility. Laboratory studies have examined its role as an actin-sequestering peptide, with research focusing on its effects on cell migration, differentiation, and angiogenesis in controlled in-vitro environments.

Actin Dynamics Cell Migration Angiogenesis

BPC-157 Tissue Research In-Vitro / Animal

The Promoting Effect of Pentadecapeptide BPC 157 on Tendon Healing

J. Applied Physiology · Chang et al., 2011

An in-vitro and animal study of BPC-157 on cultured tendon fibroblasts (tenocytes). BPC-157 significantly accelerated the outgrowth of tendon explants, increased cell survival under stress, and enhanced fibroblast migration in a dose-dependent manner. Microarray analysis identified upregulation of the growth-hormone receptor, offering a candidate mechanism for the compound's documented tendon-repair effects.

Tendon Fibroblasts Cell Migration GH Receptor

View the full research library →